216 related articles for article (PubMed ID: 26747300)
1. Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1/Nrf2-mediated inhibition of p38 MAPK pathway.
Gu L; Tao X; Xu Y; Han X; Qi Y; Xu L; Yin L; Peng J
Toxicol Appl Pharmacol; 2016 Feb; 292():19-29. PubMed ID: 26747300
[TBL] [Abstract][Full Text] [Related]
2. Potent effects of dioscin against liver fibrosis.
Zhang X; Han X; Yin L; Xu L; Qi Y; Xu Y; Sun H; Lin Y; Liu K; Peng J
Sci Rep; 2015 Apr; 5():9713. PubMed ID: 25853178
[TBL] [Abstract][Full Text] [Related]
3. Dioscin alleviates dimethylnitrosamine-induced acute liver injury through regulating apoptosis, oxidative stress and inflammation.
Zhang W; Yin L; Tao X; Xu L; Zheng L; Han X; Xu Y; Wang C; Peng J
Environ Toxicol Pharmacol; 2016 Jul; 45():193-201. PubMed ID: 27317992
[TBL] [Abstract][Full Text] [Related]
4. Dioscin protects against coronary heart disease by reducing oxidative stress and inflammation via Sirt1/Nrf2 and p38 MAPK pathways.
Yang B; Xu B; Zhao H; Wang YB; Zhang J; Li CW; Wu Q; Cao YK; Li Y; Cao F
Mol Med Rep; 2018 Jul; 18(1):973-980. PubMed ID: 29845299
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV suppresses collagen production of activated hepatic stellate cells via oxidative stress-mediated p38 MAPK pathway.
Li X; Wang X; Han C; Wang X; Xing G; Zhou L; Li G; Niu Y
Free Radic Biol Med; 2013 Jul; 60():168-76. PubMed ID: 23459070
[TBL] [Abstract][Full Text] [Related]
6. Dioscin alleviates alcoholic liver fibrosis by attenuating hepatic stellate cell activation via the TLR4/MyD88/NF-κB signaling pathway.
Liu M; Xu Y; Han X; Yin L; Xu L; Qi Y; Zhao Y; Liu K; Peng J
Sci Rep; 2015 Dec; 5():18038. PubMed ID: 26655640
[TBL] [Abstract][Full Text] [Related]
7. The antihepatic fibrotic effects of fluorofenidone via MAPK signalling pathways.
Peng Y; Yang H; Zhu T; Zhao M; Deng Y; Liu B; Shen H; Hu G; Wang Z; Tao L
Eur J Clin Invest; 2013 Apr; 43(4):358-68. PubMed ID: 23438945
[TBL] [Abstract][Full Text] [Related]
8. Xiaochaihutang attenuates liver fibrosis by activation of Nrf2 pathway in rats.
Li J; Hu R; Xu S; Li Y; Qin Y; Wu Q; Xiao Z
Biomed Pharmacother; 2017 Dec; 96():847-853. PubMed ID: 29078262
[TBL] [Abstract][Full Text] [Related]
9. Effect of salvianolic-acid B on inhibiting MAPK signaling induced by transforming growth factor-β1 in activated rat hepatic stellate cells.
Lv Z; Song Y; Xue D; Zhang W; Cheng Y; Xu L
J Ethnopharmacol; 2010 Nov; 132(2):384-92. PubMed ID: 20599490
[TBL] [Abstract][Full Text] [Related]
10. A bioinformatic and mechanistic study elicits the antifibrotic effect of ursolic acid through the attenuation of oxidative stress with the involvement of ERK, PI3K/Akt, and p38 MAPK signaling pathways in human hepatic stellate cells and rat liver.
He W; Shi F; Zhou ZW; Li B; Zhang K; Zhang X; Ouyang C; Zhou SF; Zhu X
Drug Des Devel Ther; 2015; 9():3989-4104. PubMed ID: 26347199
[TBL] [Abstract][Full Text] [Related]
11. Emodin suppresses activation of hepatic stellate cells through p38 mitogen-activated protein kinase and Smad signaling pathways in vitro.
Wang X; Niu C; Zhang X; Dong M
Phytother Res; 2018 Dec; 32(12):2436-2446. PubMed ID: 30117601
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of quercetin on the progression of liver fibrosis through the regulation of NF-кB/IкBα, p38 MAPK, and Bcl-2/Bax signaling.
Wang R; Zhang H; Wang Y; Song F; Yuan Y
Int Immunopharmacol; 2017 Jun; 47():126-133. PubMed ID: 28391159
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation.
Zhang Y; Xu Y; Qi Y; Xu L; Song S; Yin L; Tao X; Zhen Y; Han X; Ma X; Liu K; Peng J
Toxicology; 2017 Mar; 378():53-64. PubMed ID: 28082111
[TBL] [Abstract][Full Text] [Related]
14. Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis.
Li JP; Gao Y; Chu SF; Zhang Z; Xia CY; Mou Z; Song XY; He WB; Guo XF; Chen NH
Acta Pharmacol Sin; 2014 Aug; 35(8):1031-44. PubMed ID: 24976156
[TBL] [Abstract][Full Text] [Related]
15. Rosmarinic acid counteracts activation of hepatic stellate cells via inhibiting the ROS-dependent MMP-2 activity: Involvement of Nrf2 antioxidant system.
Lu C; Zou Y; Liu Y; Niu Y
Toxicol Appl Pharmacol; 2017 Mar; 318():69-78. PubMed ID: 28115189
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of dioscin against thioacetamide-induced acute liver injury via FXR/AMPK signaling pathway in vivo.
Zheng L; Yin L; Xu L; Qi Y; Li H; Xu Y; Han X; Liu K; Peng J
Biomed Pharmacother; 2018 Jan; 97():481-488. PubMed ID: 29091898
[TBL] [Abstract][Full Text] [Related]
17. Nuclear erythroid 2-related factor 2: a novel potential therapeutic target for liver fibrosis.
Yang JJ; Tao H; Huang C; Li J
Food Chem Toxicol; 2013 Sep; 59():421-7. PubMed ID: 23793039
[TBL] [Abstract][Full Text] [Related]
18. Salvianolic acid A suppresses CCl
Li S; Wang R; Song F; Chen P; Gu Y; Chen C; Yuan Y
Drug Chem Toxicol; 2023 Mar; 46(2):304-313. PubMed ID: 35057680
[TBL] [Abstract][Full Text] [Related]
19. A novel role of glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and rat hepatic fibrosis.
Chen H; Gan Q; Yang C; Peng X; Qin J; Qiu S; Jiang Y; Tu S; He Y; Li S; Yang H; Tao L; Peng Y
J Transl Med; 2019 Aug; 17(1):280. PubMed ID: 31443720
[TBL] [Abstract][Full Text] [Related]
20. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
